CYCLOCORT
LOE ApproachingNDATOPICALCREAM
Approved
Oct 1979
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CYCLOCORT is a topical corticosteroid cream approved in 1979 for dermatological inflammatory conditions. The exact indications are not specified in available data, but topical corticosteroids are typically used to treat eczema, psoriasis, dermatitis, and other inflammatory skin disorders. As a small-molecule corticosteroid, it works by suppressing local immune and inflammatory responses in the skin.
LOE Approaching
As LOE approaches, commercial teams face portfolio contraction and may transition focus to growth-stage assets or specialty dermatology alternatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
CYCLOCORT offers limited career development opportunities as a mature, LOE-approaching topical product with no linked job openings. Professionals assigned to this product should expect focus on margin protection, cost containment, and transition planning rather than growth initiatives.
Brand ManagerField Sales
Worked on CYCLOCORT at Astellas? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.